Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
Stopped Efficacy did not meet the continuance criteria and DMC recommended to stop enrollment.
Conditions
- Bladder Cancer
- Urothelial Carcinoma
- Metastatic Urothelial Carcinoma
- Renal Pelvis Carcinoma
- Ureter Carcinoma
- Urinary Bladder Carcinoma
- Urethra Carcinoma
- Muscle Invasive Bladder Cancer
Interventions
Sponsor
pharmaand GmbH
Collaborators